Status:
UNKNOWN
The Effect of Panax Notoginseng Powders on Rheumatic Pain
Lead Sponsor:
Chengdu PLA General Hospital
Conditions:
Rheumatic Pain
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.
Eligibility Criteria
Inclusion
- had a diagnosis of classic or definite RA
- without conflict to the written, informed consent signed prior to the enrollment.
Exclusion
- uncontrolled medical problems
- organic brain syndrome
- major psychiatric disturbances
- major communicative disorders
- a history of severe noncompliance
- less than 7 years of formal education, or illiteracy
- being included in other clinical trial within the last 4 weeks
- with abnormal liver or kidney function (more than 1 time above the high normal)
- with serious cardiovascular disease
- with hematologic disease
- being in pregnancy, lactation period or under a pregnancy plan
- with severe gastrointestinal disease
- with contraindication or being allergic to the test drugs
- being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as non-steroidal anti-inflammatory drugs
- being not compatible for the trial medication, or other circumstances at the discretion of investigators
- without legal capacity or only with limited legal capacity
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02260336
Start Date
October 1 2014
End Date
December 1 2018
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA，
Chengdu, Sichuan, China, 610083